Rising Cancer Cases in India Highlight Treatment Costs and Access Challenges
India faces a rising cancer burden, with over 15 lakh new cases reported in 2024 and projections indicating a 67% increase by 2045. While advanced treatments and government measures like customs duty waivers on 17 essential cancer drugs aim to reduce costs, many patients still face significant financial challenges. Treatment expenses can reach up to Rs 30 lakh, often exceeding insurance coverage, leading to delays or abandonment of therapy, especially in rural areas. Experts emphasize the need for improved access and early care to enhance patient outcomes.
First-hand measurement across 4 sources
We measured how 4 outlets covered this story. Coverage leans balanced overall (Left 20%, Centre 75%, Right 5%). Overall sentiment is neutral (50/100). Lens Score 35/100.
Outlets measured: businessstandard, firstpost, indianexpress, hindustantimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 4 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment ranged widely across outlets — from 35/100 to 75/100 — a sign the coverage itself was contested, not just reported.
Coverage timeline
hindustantimes broke this story on 4 Feb, 07:19 am. Other outlets followed.